Here, we show that pharmacological inhibition of TGFβ signaling in DMD neuromuscular circuits remarkably rescues the DMD myofiber contraction phenotypes and partially restores AChR and NMJ volumes. This evidence concerns the gene TGFB1 and Duchenne muscular dystrophy.